Circulating N-terminal brain natriuretic peptide precursor and endothelin levels in patients with syndrome X and left

D Dudek1, L Rzeszutko, P Petkow Dimitrow

  • 1IInd Department of Cardiology, Jagiellonian University, Kopernika 17, 31-501, Krakow, Poland. mcdudek@cyf.kr.edu.pl

Insights

Patients with syndrome X and left bundle branch block show elevated N-terminal Brain Natriuretic Peptide (NT-proBNP) and endothelin-1 levels, indicating diastolic dysfunction even with preserved systolic function.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Biomarker Research

Background:

  • Syndrome X with left bundle branch block (LBBB) can lead to left ventricular (LV) dysfunction.
  • Elevated Endothelin-1 (ET-1) is common in these patients.
  • Brain Natriuretic Peptide (BNP) levels, a marker for LV dysfunction, have not been previously assessed in this cohort.

Purpose of the Study:

  • To evaluate LV diastolic function.
  • To measure N-terminal Brain Natriuretic Peptide (NT-proBNP) precursor levels.
  • To assess endothelial function biomarkers in patients with Syndrome X, LBBB, and preserved LV systolic function.

Main Methods:

  • Compared echocardiographic and neurohormonal measures in three groups: Syndrome X with LBBB (n=8), Syndrome X without LBBB (n=13), and controls (n=15).
  • Assessed NT-proBNP, ET-1, and mitral flow (E/A ratio).

Main Results:

  • Group A (Syndrome X with LBBB) exhibited significantly higher NT-proBNP levels at rest and post-exercise compared to controls.
  • Elevated ET-1 concentrations were observed in Group A compared to controls.
  • Mitral flow abnormalities, indicated by a lower E/A ratio, were found in Group A, correlating inversely with NT-proBNP levels.

Conclusions:

  • Patients with Syndrome X and LBBB have elevated NT-proBNP and ET-1, even with preserved LV systolic function.
  • LV diastolic dysfunction severity correlates with increased BNP levels, reflecting neurohormonal activation in this subgroup.
Abstract

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...